Impact of Aging on Immune Function in the Pathogenesis of Pulmonary Diseases: Potential for Therapeutic Targets

Overview

Journal Expert Rev Respir Med

Specialty Pulmonary Medicine

Date 2023 Apr 20

PMID 37078192

Authors

Sadiya Bi Shaikh

Chiara Goracci

Ariel Tjitropranoto

Irfan Rahman

Affiliations

Soon will be listed here.

Abstract

Introduction: Several immunological alterations that occur during pulmonary diseases often mimic alterations observed in the aged lung. From the molecular perspective, pulmonary diseases and aging partake in familiar mechanisms associated with significant dysregulation of the immune systems. Here, we summarized the findings of how aging alters immunity to respiratory conditions to identify age-impacted pathways and mechanisms that contribute to the development of pulmonary diseases.

Areas Covered: The current review examines the impact of age-related molecular alterations in the aged immune system during various lung diseases, such as COPD, IPF, Asthma, and alongside many others that could possibly improve on current therapeutic interventions. Moreover, our increased understanding of this phenomenon may play a primary role in shaping immunomodulatory strategies to boost outcomes in the elderly. Here, the authors present new insights into the context of lung-related diseases and describe the alterations in the functioning of immune cells during various pulmonary conditions altered with age.

Expert Opinion: The expert opinion provided the concepts on how aging alters immunity during pulmonary conditions, and suggests the associated mechanisms during the development of lung diseases. As a result, it becomes important to comprehend the complex mechanism of aging in the immune lung system.

References

Hinojosa C, Mgbemena V, Van Roekel S, Austad S, Miller R, Bose S . Enteric-delivered rapamycin enhances resistance of aged mice to pneumococcal pneumonia through reduced cellular senescence. Exp Gerontol. 2012; 47(12):958-65. PMC: 3490008. DOI: 10.1016/j.exger.2012.08.013. View

Birch J, Anderson R, Correia-Melo C, Jurk D, Hewitt G, Marques F . DNA damage response at telomeres contributes to lung aging and chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol. 2015; 309(10):L1124-37. PMC: 4652155. DOI: 10.1152/ajplung.00293.2015. View

Bullone M, Lavoie J . The Contribution of Oxidative Stress and Inflamm-Aging in Human and Equine Asthma. Int J Mol Sci. 2017; 18(12). PMC: 5751215. DOI: 10.3390/ijms18122612. View

Caramori G, Casolari P, Barczyk A, Durham A, Di Stefano A, Adcock I . COPD immunopathology. Semin Immunopathol. 2016; 38(4):497-515. PMC: 4897000. DOI: 10.1007/s00281-016-0561-5. View

Pawelec G . Hallmarks of human "immunosenescence": adaptation or dysregulation?. Immun Ageing. 2012; 9(1):15. PMC: 3416738. DOI: 10.1186/1742-4933-9-15. View

Weiss S, Han J, Darvishian F, Tchack J, Han S, Malecek K . Impact of aging on host immune response and survival in melanoma: an analysis of 3 patient cohorts. J Transl Med. 2016; 14(1):299. PMC: 5070187. DOI: 10.1186/s12967-016-1026-2. View

Iwasaki A, Foxman E, Molony R . Early local immune defences in the respiratory tract. Nat Rev Immunol. 2016; 17(1):7-20. PMC: 5480291. DOI: 10.1038/nri.2016.117. View

Halawa S, Pullamsetti S, Bangham C, Stenmark K, Dorfmuller P, Frid M . Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective. Nat Rev Cardiol. 2021; 19(5):314-331. PMC: 8647069. DOI: 10.1038/s41569-021-00640-2. View

Jackaman C, Tomay F, Duong L, Abdol Razak N, Pixley F, Metharom P . Aging and cancer: The role of macrophages and neutrophils. Ageing Res Rev. 2017; 36:105-116. DOI: 10.1016/j.arr.2017.03.008. View

10.

Weiskopf D, Weinberger B, Grubeck-Loebenstein B . The aging of the immune system. Transpl Int. 2009; 22(11):1041-50. DOI: 10.1111/j.1432-2277.2009.00927.x. View

11.

Gomez C, Boehmer E, Kovacs E . The aging innate immune system. Curr Opin Immunol. 2005; 17(5):457-62. DOI: 10.1016/j.coi.2005.07.013. View

12.

Buist A, McBurnie M, Vollmer W, Gillespie S, Burney P, Mannino D . International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007; 370(9589):741-50. DOI: 10.1016/S0140-6736(07)61377-4. View

13.

Sansoni P, Vescovini R, Fagnoni F, Biasini C, Zanni F, Zanlari L . The immune system in extreme longevity. Exp Gerontol. 2007; 43(2):61-5. DOI: 10.1016/j.exger.2007.06.008. View

14.

Kumar V . Pulmonary Innate Immune Response Determines the Outcome of Inflammation During Pneumonia and Sepsis-Associated Acute Lung Injury. Front Immunol. 2020; 11:1722. PMC: 7417316. DOI: 10.3389/fimmu.2020.01722. View

15.

Hajishengallis G . Too old to fight? Aging and its toll on innate immunity. Mol Oral Microbiol. 2010; 25(1):25-37. PMC: 2839454. DOI: 10.1111/j.2041-1014.2009.00562.x. View

16.

Liu Y, Li Z, Xiao H, Xie B, He J, Song M . USP13 Deficiency Impairs Autophagy and Facilitates Age-related Lung Fibrosis. Am J Respir Cell Mol Biol. 2022; 68(1):49-61. DOI: 10.1165/rcmb.2022-0002OC. View

17.

Lopez-Otin C, Blasco M, Partridge L, Serrano M, Kroemer G . The hallmarks of aging. Cell. 2013; 153(6):1194-217. PMC: 3836174. DOI: 10.1016/j.cell.2013.05.039. View

18.

Shivshankar P, Boyd A, Le Saux C, Yeh I, Orihuela C . Cellular senescence increases expression of bacterial ligands in the lungs and is positively correlated with increased susceptibility to pneumococcal pneumonia. Aging Cell. 2011; 10(5):798-806. PMC: 3173515. DOI: 10.1111/j.1474-9726.2011.00720.x. View

19.

Schneider J, Rowe J, Garcia-de-Alba C, Kim C, Sharpe A, Haigis M . The aging lung: Physiology, disease, and immunity. Cell. 2021; 184(8):1990-2019. PMC: 8052295. DOI: 10.1016/j.cell.2021.03.005. View

20.

Toapanta F, Ross T . Impaired immune responses in the lungs of aged mice following influenza infection. Respir Res. 2009; 10:112. PMC: 2785782. DOI: 10.1186/1465-9921-10-112. View